Pharming Group N.V. (PHAR) stock
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.95−0.45 (-3.36%)
Close on Nov 12, 2026Market cap $908.68MP/E 323.8Yield –
Pharming cash
Cash and short-term investments held at the end of each period.
Pharming's cash was $145.31M at Dec 31, 2025. For fiscal 2025 it was $145.31M, up 164.5% from the year before. The highest annual figure on record is $207.34M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $145.31M | +164.5% |
| FY2024 | Dec 31, 2024 | $54.94M | -11.0% |
| FY2023 | Dec 31, 2023 | $61.74M | -70.2% |
| FY2022 | Dec 31, 2022 | $207.34M | +8.0% |
| FY2021 | Dec 31, 2021 | $191.92M | -6.5% |
| FY2020 | Dec 31, 2020 | $205.16M | +175.9% |
| FY2019 | Dec 31, 2019 | $74.35M | -19.1% |
| FY2018 | Dec 31, 2018 | $91.87M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $145.31M | -24.3% |
| Q4 FY2024 | Dec 31, 2024 | $54.94M | -73.2% |
| Q4 FY2023 | Dec 31, 2023 | $61.74M | -17.0% |
| Q4 FY2022 | Dec 31, 2022 | $207.34M | +125.7% |
| Q4 FY2021 | Dec 31, 2021 | $191.92M | – |
| Q4 FY2020 | Dec 31, 2020 | $205.16M | – |
| Q4 FY2019 | Dec 31, 2019 | $74.35M | – |
| Q4 FY2018 | Dec 31, 2018 | $91.87M | – |
See a number that looks wrong?